FLFei Kean Loh

Fei Kean Loh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fei Kean Loh has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Andres F. Vallejo

    Clinical and Experimental Sciences, Sir Henry Wellcome Laboratories, Faculty of Medicine, University of Southampton, Southampton, UK

    1 shared publication
  • Bryce Vilaysane

    Department of Biology, The University of Texas at Arlington, Arlington, Texas, USA

    1 shared publication
  • Catherine Wei Min Ong

    Infectious Diseases Translational Research Programme, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

    1 shared publication
  • Char Loo Tan

    Department of Pathology, National University Hospital, Singapore

    1 shared publication
  • Chen Bai

    Infectious Diseases Translational Research Programme, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

    1 shared publication
  • Chester Lee Drum

    Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

    1 shared publication

Latest Publications

  • Open Access

    MMPs and NETs are detrimental in human CNS-tuberculosis and MMP inhibition in a mouse model improves survival

    by Xuan Ying Poh, Fei Kean Loh, Chen Bai, Hai Tarng Chong, Wei Keat Teo, Jia Mei Hong, Qing Hao Miow, Pei Min Thong, Bryce Vilaysane, Ting Huey Hu, et al.

    Despite anti-tuberculous treatment (ATT), central nervous system tuberculosis (CNS-TB) still cause permanent neurological deficits and death. To identify prognostic factors, we profiled a prospective cohort of tuberculous meningitis (TBM) and non-TBM patients. We determined significantly increased cerebrospinal fluid (CSF) matrix metalloproteinases (MMPs) and neutrophil extracellular traps (NETs) are up-regulated in TBM patients with neuroradiological abnormalities and poor outcomes. To dissect mechanisms, we created a CNS-TB murine model which show neutrophil-rich necrotizing pyogranulomas with MMP-9 and NETs colocalizing, resembling human CNS-TB. Spatial transcriptomic analysis of both human and murine CNS-TB demonstrates a highly-inflamed and neutrophil-rich microenvironment of inflammatory immune responses, extracellular matrix degradation and angiogenesis within CNS-TB granulomas. Murine CNS-TB treated with ATT and MMP inhibitors SB-3CT or doxycycline show significantly suppressed NETs with improved survival. MMP inhibition arms show attenuated inflammation and well-formed blood vessels within granulomas. Adjunctive doxycycline is highly promising to improve CNS-TB outcomes and survival.